Needham reiterated a Hold rating for ResMed (NYSE:RMD), highlighting the company's second quarter fiscal year 2025 performance. ResMed reported revenue and earnings per share (EPS) that surpassed ...

The order, widely expected to be challenged in court, could block recipients from being able to receive the treatments and ...

“The low cost of living, warm weather, and amazing views make it a top choice for U.S. retirees,” Fournier notes. “ Panama’s ...

Will the federal government freeze financial assistance or not? Who will be affected if it does? Those questions have been ...

In the first national study of urinary incontinence among assisted living residents, New York researchers found that the condition significantly increased the probability of those residents being ...

The New Hampshire senator's son, who lives with severe cerebral palsy, inspired her viral moment in Thursday's hearing for ...

Due to its significant market share and high gross margins in a structurally growing industry, ResMed has posted an average return on invested capital, or ROIC, of 20% over the last decade. We ...

A new study finds differences in spending on long-term services and supports (LTSS) between people with dual eligibility for ...

The Jan. 28 executive order directs federal regulators to cut insurance coverage for hormonal or surgical treatments that ...

RFK Jr.'s second Senate confirmation hearing focused on vaccines, Medicare, diversity, and science. Key Republicans were reticent to show support.

A show trial is an official proceeding that is conducted primarily for propaganda purposes rather than a tribunal seeking ...

The GOP senator and former physician expressed misgivings about whether Trump’s controversial HHS pick could be trusted with ...